First-Line Mood Stabilizer for Bipolar Disorder
Lithium or valproate should be your first-line mood stabilizer for maintenance treatment of bipolar disorder, with lithium preferred when laboratory monitoring is available. 1
Acute Mania Treatment
For acute manic episodes, choose from:
- Lithium (first-line)
- Valproate (first-line)
- Carbamazepine (first-line)
- Haloperidol or second-generation antipsychotics as alternatives 1
The choice depends on monitoring capabilities—lithium should only be initiated where close clinical and laboratory monitoring are available 1. This is a critical safety consideration, not optional.
Lithium Dosing and Monitoring
Acute Mania Phase
- Starting dose: 600 mg three times daily (1800 mg/day total)
- Target serum level: 1.0-1.5 mEq/L
- Monitoring frequency: Twice weekly until stable 2
Maintenance Phase
- Typical dose: 300 mg three to four times daily (900-1200 mg/day)
- Target serum level: 0.6-0.8 mEq/L (standard therapeutic range) 3, 4
- Monitoring frequency: Every 2 months minimum in stable patients 2
Critical timing: Draw blood samples 8-12 hours after the previous dose for accurate levels 2. Do not rely solely on serum levels—clinical assessment is mandatory 2.
Age-Specific Adjustments
For patients aged 60-79 years: target 0.4-0.8 mmol/L For patients ≥80 years: target 0.4-0.7 mmol/L 5, 4
Elderly patients exhibit toxicity at levels tolerated by younger adults and require reduced dosing 2.
Required Monitoring Parameters
Before initiating lithium:
- Renal function (creatinine, eGFR)
- Thyroid function (TSH, free T4)
- Electrolytes
- Pregnancy test in women of childbearing age
During maintenance:
- Renal function: every 6-12 months 3, 6
- Thyroid function: every 6-12 months 3
- Lithium level: every 2 months minimum 2
- More frequent monitoring with interacting medications (diuretics, ACE inhibitors, NSAIDs) 4, 6
Absolute Contraindications to Lithium
Do not prescribe lithium if the patient has: 2
- Significant renal disease
- Significant cardiovascular disease
- Severe debilitation or dehydration
- Sodium depletion
- Current diuretic use (relative contraindication requiring extreme caution)
If the psychiatric indication is life-threatening and other treatments fail, lithium may be used with daily serum level monitoring and hospitalization 2.
Alternative When Lithium is Contraindicated
Valproate is the preferred alternative when lithium cannot be used 1. It requires less intensive laboratory monitoring than lithium but still needs:
- Baseline liver function tests
- Complete blood count
- Periodic monitoring during treatment
Lamotrigine is another evidence-based alternative, particularly effective for maintenance treatment and bipolar depression prevention 7, 8.
Maintenance Duration
Continue mood stabilizer treatment for at least 2 years after the last bipolar episode 1. Decisions to continue beyond 2 years should involve a mental health specialist 1.
Common Pitfalls to Avoid
Rapid discontinuation: Never abruptly stop lithium—this dramatically increases relapse risk. Taper gradually over weeks to months 9.
Inadequate monitoring: Lithium toxicity can develop insidiously. Signs at 1.0-1.5 mEq/L include tremor, polyuria, and GI upset. Levels >1.5 mEq/L cause confusion, ataxia, and seizures 2, 6.
Ignoring drug interactions: NSAIDs, ACE inhibitors, ARBs, and thiazide diuretics all reduce lithium clearance and increase toxicity risk 4, 6. Adjust lithium dose and monitor more frequently when these are added.
Dehydration: Instruct patients to maintain consistent fluid and salt intake. Dehydration from illness, exercise, or dietary changes can precipitate toxicity 6.
Using antidepressants as monotherapy: Never use antidepressants alone in bipolar disorder—they destabilize mood and can trigger mania 1, 7, 10. If needed for bipolar depression, always combine with a mood stabilizer (lithium or valproate) 1.
Special Populations
Pregnancy: Lithium carries teratogenic risk (cardiac malformations). Discuss risks/benefits; if continued, use lowest effective dose with frequent monitoring. Consider switching to alternatives in first trimester if possible 9.
Children/Adolescents: Lithium is FDA-approved for ages ≥12 years for acute mania and maintenance 7. Standard therapy includes lithium, valproate, or atypical antipsychotics 7.
Adjunctive Psychosocial Treatment
Psychoeducation should be routinely offered to all patients with bipolar disorder and their families 1. Cognitive behavioral therapy and family interventions enhance outcomes when trained professionals are available 1.